| Assets | — | — |
| Current assets | — | — |
| Cash and cash equivalents | 3,300a | 3,226a |
| Accounts receivables, net of allowance for credit losses | 3,059a | 3,408a |
| Inventories | 3,007a | 4,021a |
| Prepaid expenses | 1,006a | 1,255a |
| Other current assets | 409a | 504a |
| Assets held for sale | 1,771a | 70a |
| Total current assets | 12,552a | 12,485a |
| Deferred income taxes | 1,799a | 1,812a |
| Other non-current assets | 462a | 470a |
| Property, plant and equipment, net | 4,581a | 5,750a |
| Operating lease right-of-use assets | 367a | 397a |
| Identifiable intangible assets, net | 4,418a | 5,387a |
| Goodwill | 15,147a | 17,177a |
| Total assets | 39,326a | 43,479a |
| Liabilities and equity | — | — |
| Current liabilities | — | — |
| Short-term debt | 1,781a | 1,672a |
| Sales reserves and allowances | 3,678a | 3,535a |
| Accounts payables | 2,203a | 2,602a |
| Employee-related obligations | 624a | 611a |
| Accrued expenses | 2,792a | 2,771a |
| Other current liabilities | 1,020a | 1,044a |
| Liabilities held for sale | 698a | 13a |
| Total current liabilities | 12,796a | 12,247a |
| Long-term liabilities | — | — |
| Deferred income taxes | 483a | 606a |
| Other taxes and long-term liabilities | 4,028a | 4,019a |
| Senior notes and loans | 16,002a | 18,161a |
| Operating lease liabilities | 296a | 320a |
| Total long-term liabilities | 20,809a | 23,106a |
| Total liabilities | 33,606a | 35,353a |
| Redeemable non-controlling interests | 340a | 0a |
| Equity | — | — |
| Teva shareholders’ equity | — | — |
| Ordinary shares of NIS 0.10 par value per share | 58a | 57a |
| Additional paid-in capital | 27,764a | 27,807a |
| Accumulated deficit | -15,173a | -13,534a |
| Accumulated other comprehensive loss | -3,148a | -2,697a |
| Treasury shares | -4,128a | -4,128a |
| Non-controlling interests | 7a | 620a |
| Total equity | 5,380a | 8,126a |
| Total liabilities, redeemable non-controlling interests and equity | 39,326a | 43,479a |